28
Pharma & HealthcareAvoid
Baroda BNP Paribas Health And Wellness
Baroda BNP Paribas · Direct–Growth · rank #15 of 19 by Smart Score
Data updated
Trailing returns
1 Year
5.8%
+10.5% vs index
3 Years
—
5 Years
—
Since launch
2.7%
Year-by-year performance
2026
+8.5%+14.6% vs index
Why this score
Baroda BNP Paribas Health And Wellness scores 28/100 — #15 of 19 Pharma & Healthcare fund (Avoid). It stands out for volatility — beating 97% of peers on volatility. The main drag is its sharpe ratio (better than only 3% of peers).
Each bar shows the fund's percentile vs Pharma & Healthcare peers — a longer bar beats more of the category.
Sharpe ratio-0.32 · 3rd percentile in category
Volatility11.67 · 97th percentile in category
Expense ratio1.51% · 5th percentile in category
Sortino ratio-0.44 · 3rd percentile in category
Alpha1.53 · 22nd percentile in category
1Y return5.84% · 26th percentile in category
Top holdings
1.Sun Pharmaceutical Industries Ltd8.58%
2.Torrent Pharmaceuticals Ltd7.88%
3.Divi's Laboratories Ltd7.82%
4.Ipca Laboratories Ltd6.13%
5.Laurus Labs Ltd6.09%
33 disclosed equity positions · portfolio as of Sept 2026 · weights are % of total corpus.